Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Neuroblastoma × Topotecan × Clear all

Phase

Phase 2 16 Phase 1 13 Phase 3 6 Phase 1/2 2 Phase NA 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroectodermal Tumors, Primitive, Peripheral 2 Retinoblastoma 1 Ovarian Neoplasms 1 Neuroblastoma 1 Lymphoma 1 Central Nervous System Neoplasms 1

Interventions

Therapeutics 3 Isotretinoin 3 Etoposide 3 Cyclophosphamide 3 Vincristine 2 Stem Cell Transplantation 2 Radiotherapy, Image-Guided 2 Radiotherapy 2 Psychiatric Rehabilitation 2 Melphalan 2 Granulocyte-Macrophage Colony-Stimulating Factor 2 Granulocyte Colony-Stimulating Factor 2 Dexamethasone 2 Cisplatin 2 Carboplatin 2 Calcium Dobesilate 2 Aprepitant 2 sargramostim 1 pegfilgrastim 1 humanized 3F8 anti-GD2 monoclonal antibody 1 hetrombopag 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 Voriconazole 1 Traumeel S 1 Topotecan 1 Sugars 1 Spermine Synthase 1 Ropivacaine 1 Radiation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02786719 2020-03-12

SPRING

Baylor College of Medicine

Phase NA Completed

13 enrolled 13 charts

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡